The chemical and pharmaceutical industry is in the midst of a structural transformation. Cost-cutting programs, site adjustments, and efficiency improvements are currently shaping the agenda of many companies. Yet one crucial question remains: Where will tomorrow’s growth come from?

Dr. Hermann Schiegg and Ole Hofmann address this question in their latest article for CHEManager. The authors explain why optimization measures alone are not sufficient in the long term and why companies should once again focus more strongly on identifying new market opportunities.

At the heart of their approach is the so-called “What does it take?” mindset, which Santiago Advisors has observed in numerous conversations with companies in the United States. Rather than primarily assessing opportunities through the lens of potential risks, the focus is on what it takes to successfully enter and develop new markets. This mindset is complemented by the systematic “Santiago Opportunity Radar,” which enables companies to identify, assess, and test new growth opportunities at an early stage.

You can find the full article in the latest issue of CHEManager as well as directly here as a PDF available for download.

You can find the full article here in the current issue of CHEManager, as well as directly here as a PDF for you to download.